Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.
Individuals with severe psychiatric disorders are more likely than the population at large to develop metabolic derangements such as overweight and diabetes. Cardiovascular disease is also more frequently seen in this group. Contributing factors may include inappropriate diet or lack of physical activity, but antipsychotic medication may also play a role. Seven Swedish specialist medical societies have collaborated in formulating a set of concise clinically applicable guidelines-reproduced here in modified form-for the prevention and management of metabolic risk in this patient group. The importance of implementation is emphasized.
Gothefors
Dan
D
Karsudden Hospital, Katrineholm, Sweden. dan.gothefors@dll.se
Adolfsson
Rolf
R
Attvall
Stig
S
Erlinge
David
D
Jarbin
Håkan
H
Lindström
Kjell
K
von Hausswolff-Juhlin
Yvonne Linné
YL
Morgell
Roland
R
Toft
Eva
E
Osby
Urban
U
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D006801:Humans; D006943:Hyperglycemia / Q000628:therapy; D006949:Hyperlipidemias / Q000628:therapy; D001523:Mental Disorders / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D024821:Metabolic Syndrome / Q000517:prevention & control* / Q000523:psychology / Q000628:therapy; D009765:Obesity / Q000517:prevention & control / Q000628:therapy
D014150:Antipsychotic Agents